Inspiration Healthcare Group PLC shares rose 6.4% to 18.35p after the neonatal medical devices maker reported full-year revenue ahead of expectations and a sharp reduction in net debt.
Revenue for the year to 31 January 2026 climbed 24% to £47.5 million, above consensus forecasts of £44.1 million. Second half revenue rose 10.3% to £23.5 million.
Adjusted EBITDA is expected to be in line with market expectations of £2.8 million. The company said performance reflected sales mix effects.
Net debt fell 39% to £5.1 million, down £3.2 million year-on-year, helped by reductions in inventory and receivables under its ‘Back to Basics’ strategy.
During the year the group signed a three-year purchasing agreement with one of the largest hospital networks in the United States through its Airon subsidiary. The deal includes an initial order for 150 ventilators and accessories and is expected to generate ongoing consumables and service revenue.
Chief executive Raffi Stepanian said: “FY26 represents a year of good progress for Inspiration Healthcare, with full year revenues increasing to £47.5 million and adjusted EBITDA expected to be in line with market expectations.”
He added that the group ended the year with “encouraging sales momentum and a robust pipeline” heading into the 2027 financial year.